{"id":"W2890032742","doi":"10.1200/jco.2017.35.15_suppl.5524","title":"Phase II study of cabozantinib (cabo) in patients (pts) with recurrent/metastatic endometrial cancer (EC): A study of the Princess Margaret, Chicago, and California phase II consortia.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Cancer Care Ontario; Juravinski Cancer Centre; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Cohort; Progression-free survival; Oncology; Mucositis; Phases of clinical research; Cabozantinib; Endometrial cancer; Cancer; Chemotherapy; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002784793,0.001206883,0.00146315,0.0003752105,0.0004509724,0.0006361888,0.0006634305,0.0009676103,0.004368498],"category_scores_gemma":[0.001315859,0.0006585707,0.001030893,0.000572045,0.0008559386,0.0004974915,0.0003338789,0.001701547,0.0007328856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00106463,"about_ca_system_score_gemma":0.002349234,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003567562,"about_ca_topic_score_gemma":0.0104752,"domain_scores_codex":[0.9994048,0.0003795326,0.00002194235,0.00008892958,0.00004642524,0.00005831488],"domain_scores_gemma":[0.9988744,0.000183727,0.0001983821,0.00009134298,0.00007330772,0.0005788286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8710989,0.0231156,0.01716588,0.0008377762,0.001591663,0.0001736853,0.0003151585,0.001359783,0.01744736,0.0002226712,0.005123844,0.0615476],"study_design_scores_gemma":[0.7656872,0.1980132,0.02922601,0.00004521118,0.0008277219,0.0002423822,0.0000732991,0.0006383023,0.0009394832,0.0001137847,0.004171364,0.00002217928],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9841385,0.004806489,0.0005437362,0.0005698725,0.0001062714,0.004543838,0.002625422,0.00009623993,0.002569625],"genre_scores_gemma":[0.9814519,0.003178101,0.002156275,0.001046704,0.0001992778,0.004389818,0.004590734,0.00003618425,0.002950897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004368498,"threshold_uncertainty_score":0.01472753,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1436823454799002,"score_gpt":0.4800996152587704,"score_spread":0.3364172697788701,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}